查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2095018

基因合成市場：全球市場預測（2026-2032）

Gene Synthesis Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，基因合成市場規模將達到 75.1 億美元，複合年成長率為 16.29%。

主要市場統計數據
基準年（2025 年） 26.1億美元
預計年份（2026年） 30.2億美元
預測年份（2032年） 75.1億美元
複合年成長率（） 16.29%

基因合成是一門基於數位設計，利用酶促和化學方法構建DNA序列的技術，使研究人員和製造商無需依賴天然模板即可獲得客製化基因、基因片段、文庫、調控元件和通路組分。該領域是合成生物學、疫苗研究、精準醫療、農業生物技術、工業酵素、診斷以及細胞和基因療法開發的基礎技術。市場需求源自於加速設計-建構-測試-學習循環、提高序列準確性、實現可擴展的寡核苷酸組裝以及確保可靠交付複雜構建體（例如高GC含量序列、重複區域、抗體文庫、CRISPR元件和密碼子最佳化基因）的需求。監管和生物安全問題也是推動基因合成技術應用的關鍵因素。供應商和使用者越來越重視序列篩檢、客戶檢驗、文件記錄和品管等規範，以支援合法研究並降低濫用風險。在這種環境下，基因合成的現狀由技術性能、交付時間、數據完整性、合規能力以及將合成的 DNA 整合到下游工作流程（如克隆、表達、基因組編輯、mRNA 模板創建和功能基因組學）的能力來定義。

基因合成領域的變革性變化

基因合成領域正經歷著一場結構性變革，從簡單的DNA序列合成轉向整合、自動化且以品質為導向的生物設計基礎設施。高通量寡核苷酸合成、糾錯、基於次世代定序的品質評估以及自動化克隆技術的進步，在提高合成構建體可靠性的同時，也減少了人工操作的瓶頸。同時，使用者正從單基因計畫轉向多文庫、通路工程、蛋白質最佳化和大規模變異體生成，更加重視資訊學、設計規則和工作流程的互通性。此外，隨著合成生物學擴展到治療、永續化學品、食品技術和生物基製造等領域，對可重複性、可追溯性和生物安全管理的審查也日益嚴格。公共衛生領域在快速疫苗平台開發方面的經驗，再次印證了快速DNA合成的戰略價值，而全球生物安全討論也使負責任的序列篩檢成為一項核心操作要求。這些變化正在創造一個更成熟的環境，在這個環境中，服務可靠性、安全的數位訂購、檢驗的品質指標以及與自動化實驗室平台的兼容性，與合成能力本身一樣重要。

人工智慧對基因合成的累積影響

人工智慧 (AI) 透過改進序列的設計、最佳化、篩檢和整合到生物系統中的方式，正在為基因合成帶來實質的變革。 AI 驅動的模型可以輔助密碼子最佳化、啟動子和核醣體結合位點選擇、蛋白質序列設計、抗體和酶工程、代謝途徑平衡以及合成難度預測。機器學習還可用於識別問題基序、二級結構、重複序列、極端 GC 含量以及與低組裝成功率相關的序列，從而幫助使用者在訂購前重新設計構建體。在實驗室中，AI 驅動的自動化可以改善寡核苷酸庫規劃、組裝策略、錯誤校正以及品管結果的解讀。其最顯著的累積影響是縮短了「設計、建造、測試、學習」的週期。數位模型產生更多檢驗的假設，合成的 DNA 將這些設計轉化為實體構建體，而實驗結果則回饋到改進的模型中。然而，AI 也增加了管治的必要性，因為更強大的設計工具降低了創建生物活性序列的門檻。因此，負責任的實施需要將人工智慧驅動的生產力提升與序列篩檢、可審計性、客戶審查、安全的數據處理以及遵守不斷發展的生物安全和生物安保指南相結合。

基因合成的區域分析

亞太地區正成為基因合成技術應用的重要中心，這主要得益於生物技術製造業的擴張、政府支持的生命科學計畫、不斷成長的學術研究成果，以及合成生物學在醫療保健、農業和工業生物技術領域日益廣泛的應用。中國、印度、日本、韓國、澳洲和東南亞國協正在加強其在基因組學、疫苗研發、生物製造和精準醫療方面的能力，從而持續推動對客製化DNA和基因庫服務的需求。在歐洲，與藥物研發、工業生物技術、學術聯盟以及強調負責任創新、資料管治和生物安全的政策相關的需求十分強勁。同時，北美仍保持著重要的影響力，這得益於其集中的前沿生物醫學研究、細胞和基因療法開發、合成生物學創新、創業投資驅動的生物技術活動，以及來自大學、研究型醫院和合約研究生態系統的強勁需求。在拉丁美洲，基因組學相關計畫、感染疾病研究、農業生物技術和公共衛生應用正在蓬勃發展，其中巴西和墨西哥在生物製造的研究能力和興趣方面發揮著重要作用。非洲的基因合成機會與病原體監測、疫苗研發、作物改良以及基因組學領域的能力建設密切相關，但基礎設施、資金籌措持續性和熟練人才的匱乏仍然是許多市場的主要阻礙因素。在中東，基因組學、醫療轉型和生物技術基礎設施的投資正在增加，尤其是在那些透過生命科學和先進醫學研究推動經濟多元化的國家。

基因合成的主要群體特異性分析

北約成員國在基因合成領域佔有重要地位，因為基因合成技術與生物防禦、病原體防範、安全供應鏈以及兩用物項研究的管治密切相關。這提升了負責任的DNA合成標準和可靠的篩檢方法在盟國研究生態系統中的重要性。七國集團（G7）擁有成熟的研究基礎設施以及生命科學領域的大量公共和私人投資，持續推動合成生物學、精準醫療、疫苗平台、生技藥品開發和生物安全政策等領域的先進應用。金磚國家（BRICS）擁有中國和印度龐大的研發和製造生態系統、巴西在農業生物技術領域的優勢、俄羅斯的生命科學研究基礎以及南非在生物醫學和公共衛生研究領域的區域性作用，共同構成了基因合成技術發展的多元化沃土。歐盟憑藉其嚴格的監管和科研密集型環境，支持基因合成技術在藥物研發、工業生物技術、食品和農業創新以及跨境學術計畫等領域的應用。此外，品管系統、資料保護和生物安全也備受重視。在東南亞國協，隨著各國政府對生物醫學研究、疫苗研發、農業生物技術以及產研合作的支持，生物醫學研究的重要性日益凸顯。同時，新加坡、泰國、馬來西亞、印尼、越南和菲律賓正在為基因組學和合成生物學能力的廣泛且不斷成長的需求做出貢獻。海灣合作理事會（GCC）國家正透過長期策略推動基因合成相關活動，以建立生物技術能力，作為國家醫療現代化、基因組醫學舉措、研究型醫院建設和經濟多元化的一部分。

各國基因合成分析

中國在基因組學、合成生物學、生物製造和應用生物技術領域佔據重要地位，而美國則透過先進的合成生物學、製藥、學術界、國防醫學以及細胞和基因治療生態系統，引領先進基因合成技術的應用，尤其注重快速原型製作、自動化工作流程和生物安全意識強的篩檢。日本專注於精準生命科學、工業生物技術和高品質的研究體系，而印度則透過疫苗生產、生物製藥研究、生物資訊人才和農業生物技術迅速擴張。德國透過工業生物技術、藥物研發和工程主導的生命科學創新來滿足需求，而英國則保持其在基因組學、合成生物學和轉化醫學方面的優勢。澳洲透過醫學研究、感染疾病控制、農業和大學主導的生物技術來滿足基因合成的需求，而法國則專注於生物醫學研究、疫苗和生物製造。韓國透過大力投資生物製藥製造、基因組學、診斷技術和生物技術創新，取得了顯著進展；義大利和西班牙則透過學術基因組學、臨床研究和生物技術叢集做出貢獻。加拿大則透過基因組學研究、疫苗開發、農業生物技術和公共研究網路做出貢獻；俄羅斯儘管面臨地緣政治和供應鏈方面的限制，但仍在分子生物學、疫苗科學和研究應用領域保持活躍。巴西已成為拉丁美洲基因合成在農業、感染疾病研究和生物經濟發展領域應用的重要中心；而墨西哥的需求則集中在生物技術教育、診斷、農業研究以及與北美生命科學供應鏈的整合等方面。

為基因合成領域的領導者提供的實用建議

產業領導者應優先考慮整合基因合成工作流程，將數位序列設計、生物安全篩檢、自動化組裝、建構定序、基於定序的檢驗以及下游克隆和表達服務連接起來。對人工智慧驅動的設計工具的投資應輔以透明的檢驗、安全的資料管治以及用於雙用途風險管理的人工監督。各組織需要加強品質品管體系，以確保序列準確性、文件記錄、批次可追溯性、污染控制和可重複性，尤其是在處理治療、診斷和疫苗開發等受監管應用時。供應商和使用者應採用廣泛認可的負責任的DNA合成實踐，包括客戶檢驗和相關序列的篩檢，並針對模糊不清的需求建立清晰的升級流程。為了增強競爭力，產業領導者應建構處理複雜序列、長構建體、多文庫、密碼子最佳化以及特定應用格式（例如CRISPR模板、抗體文庫和mRNA生產模板）的能力。與學術機構、生物製造設施、公共衛生網路和自動化平台提供者建立策略夥伴關係可以加速技術的應用。此外，各組織應透過以下方式降低供應鏈風險：使關鍵試劑的來源多樣化，提高其在不同地區的服務韌性，並使其營運適應當地數據、生物安全和進出口要求。

分析方法

本報告透過對已核實的公共領域資訊進行二手研究和分析整合而編制，這些資訊包括科學文獻、監管指南、公共衛生資訊來源、行業標準討論、專利和創新趨勢、政府生物技術戰略以及基因組學、合成生物學和生物安全管治的檢驗進展。本報告著重於定性證據，而非市場規模、市場佔有率或預測。關鍵主題的評估涵蓋技術演進、應用需求、監管和生物安全考量、區域研究能力、生產準備以及應用促進因素。區域、群體和國家層面的洞察分析是基於可觀察指標，例如生命科學領域的公共投資、基因組學舉措、生物製造活動、學術和臨床研究生態系統、農業生物技術的重要性以及負責任創新的政策重點。人工智慧相關分析是基於序列最佳化、蛋白質工程、文庫設計、自動化和兩用風險緩解等方面的已記錄用例。為了確保調查結果與可靠資訊來源的一致性，我們排除了推測性的說法和未經證實的數字預測，以保持其對管理層的可信度和相關性。

結論

基因合成已發展成為現代生物技術的戰略驅動力，它將數位生物設計與物理DNA建構結合，並廣泛應用於醫學、農業、工業生物技術、診斷和公共衛生等領域。自動化、人工智慧驅動的序列設計、對品質檢驗更高要求以及更嚴格的生物安全管治正在改變這一領域。區域應用反映了研究基礎設施、生物製造能力、政策支援和人力資源開發方面的差異，但主要國家和經濟集團的趨勢表明，基因合成正日益與國家創新、衛生安全和生物經濟戰略緊密相連。擁有卓越技術、負責任的篩檢、安全的數據處理、工作流程整合和應用特定專業知識的行業領導者將最有能力推動合成生物學的下一階段發展。隨著基因合成變得更快、更易獲取，並與人工智慧和自動化實驗室更深入地整合，為複雜的生物學挑戰提供可靠、合規、可重複且經過科學檢驗的DNA解決方案將成為最具永續的競爭優勢。

目錄

第1章 引言

第2章 分析方法

  • 分析設計
  • 分析框架
  • 市場規模預測
  • 數據三角測量
  • 分析結果
  • 分析的前提條件
  • 分析的局限性

第3章執行摘要

  • 首席體驗長的觀點
  • 市場規模和成長趨勢
  • 市佔率分析（2025 年）
  • FPNV定位矩陣（2025）
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入（GTM）策略

第5章 市場洞察

  • 消費者分析與最終用戶觀點
  • 消費者體驗基準測試
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 成本效益分析（ROI）和成本效益分析（CBA）

第6章：人工智慧（AI）的累積影響（2026 年）

第7章 基因合成市場：依產品分類

  • 裝置
    • 自動克隆設備
    • DNA合成器
    • 微陣列平台
    • 聚合酵素連鎖反應熱迴圈儀
  • 試劑和耗材
    • 緩衝劑和其他消耗品
    • 酵素試劑盒
    • 寡核苷酸
  • 服務
    • 基礎基因合成
    • 基因複製
    • 突變引入服務

第8章 基因合成市場：依技術分類

  • 化學合成
    • H-膦酸酯合成
    • 亞磷醯胺合成
  • 酵素合成
    • 吉布森組裝
    • 金門集會
    • 連接酶鍊式反應
  • 基於PCR的合成

第9章：基因合成市場：依基因長度分類

  • 中等大小的基因序列（1–5 kb）
  • 長基因序列（超過 5 kb）
  • 短基因序列（小於1 kb）

第10章 基因合成市場：依應用領域分類

  • 抗體和疫苗生產
  • 工業生物技術
  • 分子診斷
  • 幹細胞/細胞株工程
  • 合成生物學

第11章 基因合成市場：依最終用戶分類

  • 學術和研究機構
  • 臨床/診斷檢查室
  • CRO（委外研發機構）
  • 製藥和生物技術公司

第12章 基因合成市場：依地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第13章 基因合成市場：依組別分類

  • NATO
  • G7
  • BRICS
  • EU
  • ASEAN
  • GCC

第14章 基因合成市場：依國家分類

  • 中國
  • 美國
  • 日本
  • 印度
  • 德國
  • 英國
  • 澳洲
  • 法國
  • 韓國
  • 義大利
  • 加拿大
  • 俄羅斯
  • 巴西
  • 墨西哥
  • 西班牙

第15章 競爭格局

  • 市佔率分析（2025 年）
  • FPNV定位矩陣（2025）
  • 市場集中度分析（2025 年）
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析（2025 年）
  • 產品系列分析（2025 年）
  • 基準分析（2025 年）

第16章：公司簡介

  • Agilent Technologies, Inc.
  • Ansa Biotechnologies Inc.
  • ATUM, Inc.
  • Azenta Life Sciences, Inc.
  • Bio Basic Inc.
  • BioCat GmbH
  • Biomatik Corporation
  • Bioneer Corporation
  • Camena Bioscience
  • DNA Script SA
  • Elegen Corporation
  • Eurofins Scientific SE
  • Evonetix Ltd.
  • GenScript Biotech Corporation
  • Integrated DNA Technologies, Inc.
  • Macrogen Inc.
  • Merck KGaA
  • OriGene Technologies, Inc.
  • ProMab Biotechnologies, Inc.
  • ProteoGenix SAS
  • Quintara Biosciences
  • Synbio Technologies Inc.
  • Telesis Bio, Inc.
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation
Product Code: MRR-3A2E844FEB5F

The Gene Synthesis Market is projected to grow by USD 7.51 billion at a CAGR of 16.29% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.61 billion
Estimated Year [2026] USD 3.02 billion
Forecast Year [2032] USD 7.51 billion
CAGR (%) 16.29%

Gene synthesis is the enzymatic and chemical construction of DNA sequences from digital designs, enabling researchers and manufacturers to obtain custom genes, gene fragments, libraries, regulatory elements, and pathway components without relying on natural templates. The field has become a foundational capability for synthetic biology, vaccine research, precision medicine, agricultural biotechnology, industrial enzymes, diagnostics, and cell and gene therapy development. Demand is being shaped by the need for faster design-build-test-learn cycles, higher sequence accuracy, scalable oligonucleotide assembly, and reliable delivery of complex constructs such as high-GC sequences, repetitive regions, antibody libraries, CRISPR components, and codon-optimized genes. Regulatory and biosecurity expectations are also central to adoption, as providers and users increasingly align with sequence screening, customer verification, documentation, and quality control practices to reduce misuse risk while supporting legitimate research. In this environment, the gene synthesis landscape is defined by technical performance, turnaround time, data integrity, compliance readiness, and the ability to integrate synthesized DNA into downstream workflows such as cloning, expression, genome editing, mRNA template production, and functional genomics.

Transformative Shifts in the Gene Synthesis Landscape

The gene synthesis landscape is undergoing a structural shift from transactional DNA ordering toward integrated, automated, and quality-driven biological design infrastructure. Advances in high-throughput oligonucleotide synthesis, error correction, next-generation sequencing-based quality assessment, and automated cloning are improving the reliability of synthetic constructs while reducing manual bottlenecks. At the same time, users are moving beyond single-gene projects into multiplexed libraries, pathway engineering, protein optimization, and large-scale variant generation, which places greater emphasis on informatics, design rules, and workflow interoperability. The expansion of synthetic biology into therapeutics, sustainable chemicals, food technology, and bio-based manufacturing is also increasing scrutiny of reproducibility, traceability, and biosafety controls. Public health experience with rapid vaccine platform development has reinforced the strategic value of rapid DNA synthesis, while global biosecurity discussions have made responsible sequence screening a core operational expectation. These shifts are creating a more mature environment in which service reliability, secure digital ordering, validated quality metrics, and compatibility with automated laboratory platforms are as important as synthesis capacity itself.

Cumulative Impact of Artificial Intelligence on Gene Synthesis

Artificial intelligence is materially changing gene synthesis by improving how sequences are designed, optimized, screened, and integrated into biological systems. AI-enabled models support codon optimization, promoter and ribosome binding site selection, protein sequence design, antibody and enzyme engineering, metabolic pathway balancing, and prediction of synthesis difficulty. Machine learning is also used to identify problematic motifs, secondary structures, repeats, extreme GC content, and sequences associated with low assembly success, helping users redesign constructs before ordering. In the laboratory, AI-assisted automation can improve planning for oligonucleotide pools, assembly strategies, error correction, and quality control interpretation. The most significant cumulative impact is the compression of the design-build-test-learn cycle: digital models generate more testable hypotheses, synthesized DNA translates those designs into physical constructs, and experimental results feed back into improved models. However, AI also heightens the need for governance because more powerful design tools can lower barriers to creating biologically active sequences. Responsible adoption therefore depends on combining AI-driven productivity with sequence screening, auditability, customer due diligence, secure data handling, and alignment with evolving biosafety and biosecurity guidance.

Key Regional Insights for Gene Synthesis

Asia-Pacific is becoming a major center for gene synthesis adoption due to expanding biotechnology manufacturing, government-supported life science programs, growing academic research output, and increasing use of synthetic biology in healthcare, agriculture, and industrial biotechnology. China, India, Japan, South Korea, Australia, and ASEAN economies are strengthening capabilities in genomics, vaccine development, biomanufacturing, and precision medicine, creating sustained demand for custom DNA and gene library services. Europe demonstrates strong demand linked to pharmaceutical research, industrial biotechnology, academic consortia, and policy emphasis on responsible innovation, data governance, and biosafety, while North America remains highly influential because of its concentration of advanced biomedical research, cell and gene therapy development, synthetic biology innovation, venture-backed biotechnology activity, and strong demand from universities, research hospitals, and contract research ecosystems. Latin America is progressing through expanding genomics initiatives, infectious disease research, agricultural biotechnology, and public health applications, with Brazil and Mexico playing important roles in research capacity and biomanufacturing interest. Africa's gene synthesis opportunity is connected to pathogen surveillance, vaccine research, crop improvement, and capacity building in genomics, although infrastructure, funding continuity, and specialized workforce availability remain key constraints across many markets. The Middle East is increasing investment in genomics, healthcare transformation, and biotechnology infrastructure, particularly in nations pursuing diversification through life sciences and advanced medical research.

Key Group Insights for Gene Synthesis

NATO member states are relevant to gene synthesis because the technology intersects with biodefense, pathogen preparedness, secure supply chains, and dual-use research governance, increasing the importance of responsible DNA synthesis standards and trusted screening practices across allied research ecosystems. G7 countries continue to shape advanced use cases in synthetic biology, precision medicine, vaccine platforms, biologics development, and biosecurity policy, supported by mature research infrastructure and significant public and private life science investment. BRICS economies collectively represent a diverse gene synthesis growth base, combining China and India's large research and manufacturing ecosystems, Brazil's agricultural biotechnology strengths, Russia's life science research base, and South Africa's role in regional biomedical and public health research. The European Union provides a highly regulated and research-intensive environment in which gene synthesis supports pharmaceutical development, industrial biotechnology, food and agriculture innovation, and cross-border academic programs, with strong attention to quality systems, data protection, and biosafety. ASEAN countries are increasingly relevant as regional governments support biomedical research, vaccine readiness, agricultural biotechnology, and university-industry collaboration, while Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines contribute to broader demand for genomics and synthetic biology capabilities. The GCC is advancing gene synthesis-related activity through national healthcare modernization, genomic medicine initiatives, research hospital development, and long-term strategies to build biotechnology capacity as part of economic diversification.

Key Country Insights for Gene Synthesis

China is a major force in genomics, synthetic biology, biomanufacturing, and applied biotechnology, while the United States leads in advanced gene synthesis utilization through deep synthetic biology, pharmaceutical, academic, defense health, and cell and gene therapy ecosystems, with strong emphasis on rapid prototyping, automated workflows, and biosecurity-aware screening. Japan focuses on precision life sciences, industrial biotechnology, and high-quality research systems, and India is expanding rapidly through vaccine production, biopharmaceutical research, bioinformatics talent, and agricultural biotechnology. Germany supports demand through industrial biotechnology, pharmaceutical research, and engineering-led life science innovation, while the United Kingdom maintains strength in genomics, synthetic biology, and translational medicine. Australia supports gene synthesis demand through medical research, infectious disease preparedness, agriculture, and university-led biotechnology, while France emphasizes biomedical research, vaccines, and biomanufacturing. South Korea is advancing through biologics manufacturing, genomics, diagnostics, and strong national investment in biotechnology innovation, while Italy and Spain contribute through academic genomics, clinical research, and biotechnology clusters. Canada contributes through genomics research, vaccine development, agricultural biotechnology, and public research networks, while Russia remains active in molecular biology, vaccine science, and research applications despite geopolitical and supply chain constraints. Brazil is a key Latin American hub for gene synthesis applications in agriculture, infectious disease research, and bioeconomy development, and Mexico's demand is linked to biotechnology education, diagnostics, agricultural research, and integration with North American life science supply chains.

Actionable Recommendations for Gene Synthesis Leaders

Industry leaders should prioritize integrated gene synthesis workflows that connect digital sequence design, biosafety screening, automated ordering, construct assembly, sequencing-based verification, and downstream cloning or expression services. Investment in AI-enabled design tools should be paired with transparent validation, secure data governance, and human oversight for dual-use risk management. Organizations should strengthen quality systems for sequence accuracy, documentation, batch traceability, contamination control, and reproducibility, particularly when serving regulated applications such as therapeutics, diagnostics, and vaccine development. Providers and users should adopt recognized responsible DNA synthesis practices, including customer verification and screening for sequences of concern, while maintaining clear escalation processes for ambiguous requests. To improve competitiveness, leaders should develop capabilities for difficult sequences, long constructs, multiplexed libraries, codon optimization, and application-specific formats such as CRISPR templates, antibody libraries, and mRNA production templates. Strategic partnerships with academic centers, biomanufacturing facilities, public health networks, and automation platform providers can accelerate adoption. Organizations should also reduce supply chain risk by diversifying critical reagents, improving regional service resilience, and aligning operations with local data, biosafety, and import-export requirements.

Research Methodology

This executive summary is developed through secondary research and analytical synthesis of verified public-domain information from scientific literature, regulatory guidance, public health sources, industry standards discussions, patent and innovation trends, government biotechnology strategies, and documented developments in genomics, synthetic biology, and biosecurity governance. The methodology focuses on qualitative evidence rather than market sizing, market share, or forecasting. Key themes were assessed across technology evolution, application demand, regulatory and biosafety considerations, regional research capacity, manufacturing readiness, and adoption drivers. Regional, group, and country insights were structured using observable indicators such as public investment in life sciences, genomics initiatives, biomanufacturing activity, academic and clinical research ecosystems, agricultural biotechnology relevance, and policy emphasis on responsible innovation. AI-related analysis was based on documented use cases in sequence optimization, protein engineering, library design, automation, and dual-use risk mitigation. Findings were cross-checked for consistency across credible sources, and speculative claims or unsupported numerical projections were excluded to maintain reliability and executive relevance.

Conclusion

Gene synthesis has evolved into a strategic enabler of modern biotechnology, linking digital biological design with physical DNA construction for applications across medicine, agriculture, industrial biotechnology, diagnostics, and public health. The field is being reshaped by automation, AI-driven sequence design, higher expectations for quality verification, and stronger biosecurity governance. Regional adoption patterns reflect differences in research infrastructure, biomanufacturing capacity, policy support, and workforce development, while major country and economic group dynamics show that gene synthesis is increasingly tied to national innovation, health security, and bioeconomy strategies. Industry leaders that combine technical excellence with responsible screening, secure data handling, workflow integration, and application-specific expertise will be best positioned to support the next phase of synthetic biology. As gene synthesis becomes faster, more accessible, and more deeply integrated with AI and automated laboratories, the most durable advantage will come from delivering trusted, compliant, reproducible, and scientifically validated DNA solutions for complex biological challenges.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Gene Synthesis Market, by Product

  • 7.1. Introduction
  • 7.2. Instruments
    • 7.2.1. Automated Cloning Instruments
    • 7.2.2. DNA Synthesizers
    • 7.2.3. Microarray Platforms
    • 7.2.4. Thermal Cyclers
  • 7.3. Reagents & Consumables
    • 7.3.1. Buffers & Other Consumables
    • 7.3.2. Enzymes & Kits
    • 7.3.3. Oligonucleotides
  • 7.4. Services
    • 7.4.1. Basic Gene Synthesis
    • 7.4.2. Gene Cloning
    • 7.4.3. Mutagenesis Services

8. Gene Synthesis Market, by Technology

  • 8.1. Introduction
  • 8.2. Chemical Synthesis
    • 8.2.1. H-Phosphonate Synthesis
    • 8.2.2. Phosphoramidite Synthesis
  • 8.3. Enzymatic Synthesis
    • 8.3.1. Gibson Assembly
    • 8.3.2. Golden Gate Assembly
    • 8.3.3. Ligase Chain Reaction
  • 8.4. PCR Based Synthesis

9. Gene Synthesis Market, by Gene Length

  • 9.1. Introduction
  • 9.2. Medium Gene Sequences (1-5 kb)
  • 9.3. Long Gene Sequences (>5 kb)
  • 9.4. Short Gene Sequences (<1 kb)

10. Gene Synthesis Market, by Application

  • 10.1. Introduction
  • 10.2. Antibody & Vaccine Production
  • 10.3. Industrial Biotechnology
  • 10.4. Molecular Diagnostics
  • 10.5. Stem Cell & Cell Line Engineering
  • 10.6. Synthetic Biology

11. Gene Synthesis Market, by End-User

  • 11.1. Introduction
  • 11.2. Academic & Research Institutes
  • 11.3. Clinical Diagnostics Laboratories
  • 11.4. Contract Research Organizations
  • 11.5. Pharmaceutical & Biotechnology Companies

12. Gene Synthesis Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. Europe
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Africa
  • 12.6. Middle East

13. Gene Synthesis Market, by Group

  • 13.1. NATO
  • 13.2. G7
  • 13.3. BRICS
  • 13.4. European Union
  • 13.5. ASEAN
  • 13.6. GCC

14. Gene Synthesis Market, by Country

  • 14.1. China
  • 14.2. United States
  • 14.3. Japan
  • 14.4. India
  • 14.5. Germany
  • 14.6. United Kingdom
  • 14.7. Australia
  • 14.8. France
  • 14.9. South Korea
  • 14.10. Italy
  • 14.11. Canada
  • 14.12. Russia
  • 14.13. Brazil
  • 14.14. Mexico
  • 14.15. Spain

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Agilent Technologies, Inc.
  • 16.2. Ansa Biotechnologies Inc.
  • 16.3. ATUM, Inc.
  • 16.4. Azenta Life Sciences, Inc.
  • 16.5. Bio Basic Inc.
  • 16.6. BioCat GmbH
  • 16.7. Biomatik Corporation
  • 16.8. Bioneer Corporation
  • 16.9. Camena Bioscience
  • 16.10. DNA Script SA
  • 16.11. Elegen Corporation
  • 16.12. Eurofins Scientific SE
  • 16.13. Evonetix Ltd.
  • 16.14. GenScript Biotech Corporation
  • 16.15. Integrated DNA Technologies, Inc.
  • 16.16. Macrogen Inc.
  • 16.17. Merck KGaA
  • 16.18. OriGene Technologies, Inc.
  • 16.19. ProMab Biotechnologies, Inc.
  • 16.20. ProteoGenix SAS
  • 16.21. Quintara Biosciences
  • 16.22. Synbio Technologies Inc.
  • 16.23. Telesis Bio, Inc.
  • 16.24. Thermo Fisher Scientific Inc.
  • 16.25. Twist Bioscience Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL GENE SYNTHESIS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL GENE SYNTHESIS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL GENE SYNTHESIS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL GENE SYNTHESIS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL GENE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL GENE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 23. GLOBAL GENE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL GENE SYNTHESIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL GENE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL AUTOMATED CLONING INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL AUTOMATED CLONING INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AUTOMATED CLONING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DNA SYNTHESIZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DNA SYNTHESIZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DNA SYNTHESIZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MICROARRAY PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MICROARRAY PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MICROARRAY PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL THERMAL CYCLERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL THERMAL CYCLERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL THERMAL CYCLERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BUFFERS & OTHER CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BUFFERS & OTHER CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BUFFERS & OTHER CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENZYMES & KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENZYMES & KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENZYMES & KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL OLIGONUCLEOTIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL OLIGONUCLEOTIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL OLIGONUCLEOTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BASIC GENE SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BASIC GENE SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BASIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GENE CLONING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GENE CLONING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GENE CLONING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MUTAGENESIS SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MUTAGENESIS SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MUTAGENESIS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CHEMICAL SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CHEMICAL SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CHEMICAL SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL H-PHOSPHONATE SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL H-PHOSPHONATE SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL H-PHOSPHONATE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PHOSPHORAMIDITE SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PHOSPHORAMIDITE SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PHOSPHORAMIDITE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENZYMATIC SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ENZYMATIC SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENZYMATIC SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GIBSON ASSEMBLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GIBSON ASSEMBLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GIBSON ASSEMBLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GOLDEN GATE ASSEMBLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GOLDEN GATE ASSEMBLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GOLDEN GATE ASSEMBLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL LIGASE CHAIN REACTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL LIGASE CHAIN REACTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL LIGASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PCR BASED SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PCR BASED SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PCR BASED SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDIUM GENE SEQUENCES (1-5 KB) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDIUM GENE SEQUENCES (1-5 KB) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDIUM GENE SEQUENCES (1-5 KB) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL LONG GENE SEQUENCES (>5 KB) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL LONG GENE SEQUENCES (>5 KB) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL LONG GENE SEQUENCES (>5 KB) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SHORT GENE SEQUENCES (<1 KB) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SHORT GENE SEQUENCES (<1 KB) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SHORT GENE SEQUENCES (<1 KB) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANTIBODY & VACCINE PRODUCTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ANTIBODY & VACCINE PRODUCTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANTIBODY & VACCINE PRODUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL INDUSTRIAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL INDUSTRIAL BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL INDUSTRIAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL STEM CELL & CELL LINE ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL STEM CELL & CELL LINE ENGINEERING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL STEM CELL & CELL LINE ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CLINICAL DIAGNOSTICS LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CLINICAL DIAGNOSTICS LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CLINICAL DIAGNOSTICS LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE GENE SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA GENE SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA GENE SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA GENE SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST GENE SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 175. NATO GENE SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. NATO GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 177. NATO GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 178. NATO GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 179. NATO GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 180. NATO GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. NATO GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 182. NATO GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 183. NATO GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 184. NATO GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. NATO GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 186. G7 GENE SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 187. G7 GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 188. G7 GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 189. G7 GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 190. G7 GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 191. G7 GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. G7 GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 193. G7 GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 194. G7 GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 195. G7 GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. G7 GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS GENE SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION GENE SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN GENE SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 230. GCC GENE SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 231. GCC GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 232. GCC GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 233. GCC GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 234. GCC GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 235. GCC GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 236. GCC GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 237. GCC GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 238. GCC GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 239. GCC GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. GCC GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 241. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA GENE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES GENE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 264. JAPAN GENE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 265. JAPAN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 266. JAPAN GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 267. JAPAN GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 268. JAPAN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 269. JAPAN GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 270. JAPAN GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 271. JAPAN GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 272. JAPAN GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 273. JAPAN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. JAPAN GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 275. INDIA GENE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 276. INDIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 277. INDIA GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 278. INDIA GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 279. INDIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 280. INDIA GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 281. INDIA GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 282. INDIA GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 283. INDIA GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 284. INDIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 285. INDIA GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 286. GERMANY GENE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. GERMANY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 288. GERMANY GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 289. GERMANY GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 290. GERMANY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 291. GERMANY GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 292. GERMANY GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 293. GERMANY GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 294. GERMANY GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 295. GERMANY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 296. GERMANY GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 297. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 298. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 299. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 300. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 301. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 302. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 303. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 308. AUSTRALIA GENE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 309. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 310. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 311. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 312. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 313. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 314. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 315. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 316. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 317. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 318. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 319. FRANCE GENE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 320. FRANCE GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 321. FRANCE GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 322. FRANCE GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 323. FRANCE GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 324. FRANCE GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 325. FRANCE GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 326. FRANCE GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 327. FRANCE GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 328. FRANCE GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 329. FRANCE GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 330. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 331. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 332. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 333. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 334. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 335. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 336. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 337. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 338. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 339. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 340. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 341. ITALY GENE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 342. ITALY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 343. ITALY GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 344. ITALY GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 345. ITALY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 346. ITALY GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 347. ITALY GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 348. ITALY GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 349. ITALY GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 350. ITALY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 351. ITALY GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 352. CANADA GENE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 353. CANADA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 354. CANADA GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 355. CANADA GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 356. CANADA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 357. CANADA GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 358. CANADA GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 359. CANADA GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 360. CANADA GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 361. CANADA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 362. CANADA GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 363. RUSSIA GENE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 364. RUSSIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 365. RUSSIA GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 366. RUSSIA GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 367. RUSSIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 368. RUSSIA GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 369. RUSSIA GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 370. RUSSIA GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 371. RUSSIA GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 372. RUSSIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 373. RUSSIA GENE SYNTHESIS MARKET SIZE, BY END-USER